OBJECTIVE: Mirror syndrome (Ballantyne's syndrome) refers to the association of fetal hydrops and maternal preeclampsia. The aim of this study was to determine the relation and incidence between fetal hydrops and preeclampsia in our clinic. METHODS: A retrospective review of patients associated with fetal hydrops and findings with preeclampsia was used. Seventy-five cases with single pregnancy and diagnoses with nonimmune hydrops fetalis were found. According to the data 4 cases were found related with preeclampsia. RESULTS: Mirror syndrome is rarely encountered and underdiagnosed. We found a frequency of 5.3% (4 cases in 75 affected pregnancies) for single non-immune hydrops cases in which maternal hypertension occurred. Fetal outcome is depending on etiology and prognosis is mainly very low. Maternal symptoms and laboratory findings are resolving after intrauterine fetal death or delivery. CONCLUSION: Hydrops fetalis must be considered as a potential risk factor for preeclampsia. It is important that this clinical condition has a potential of about 5% for proceeding preeclampsia.
OBJECTIVE:Mirror syndrome (Ballantyne's syndrome) refers to the association of fetal hydrops and maternal preeclampsia. The aim of this study was to determine the relation and incidence between fetal hydrops and preeclampsia in our clinic. METHODS: A retrospective review of patients associated with fetal hydrops and findings with preeclampsia was used. Seventy-five cases with single pregnancy and diagnoses with nonimmune hydrops fetalis were found. According to the data 4 cases were found related with preeclampsia. RESULTS:Mirror syndrome is rarely encountered and underdiagnosed. We found a frequency of 5.3% (4 cases in 75 affected pregnancies) for single non-immune hydrops cases in which maternal hypertension occurred. Fetal outcome is depending on etiology and prognosis is mainly very low. Maternal symptoms and laboratory findings are resolving after intrauterine fetal death or delivery. CONCLUSION: Hydrops fetalis must be considered as a potential risk factor for preeclampsia. It is important that this clinical condition has a potential of about 5% for proceeding preeclampsia.
Authors: Teresa N Sparks; Billie R Lianoglou; Rebecca R Adami; Ilina D Pluym; Kerry Holliman; Jennifer Duffy; Sarah L Downum; Sachi Patel; Amanda Faubel; Nina M Boe; Nancy T Field; Aisling Murphy; Louise C Laurent; Jennifer Jolley; Cherry Uy; Anne M Slavotinek; Patrick Devine; Ugur Hodoglugil; Jessica Van Ziffle; Stephan J Sanders; Tippi C MacKenzie; Mary E Norton Journal: N Engl J Med Date: 2020-10-07 Impact factor: 91.245
Authors: Teresa N Sparks; Kao Thao; Billie R Lianoglou; Nina M Boe; Kari G Bruce; Ilina Datkhaeva; Nancy T Field; Victoria M Fratto; Jennifer Jolley; Louise C Laurent; Anne H Mardy; Aisling M Murphy; Emily Ngan; Naseem Rangwala; Catherine A M Rottkamp; Lisa Wilson; Erica Wu; Cherry C Uy; Priscila Valdez Lopez; Mary E Norton Journal: Genet Med Date: 2018-11-09 Impact factor: 8.822
Authors: Ivonne Alexandra Bedei; Alexander Graf; Karl-Philipp Gloning; Matthias Meyer-Wittkopf; Daria Willner; Martin Krapp; Sabine Hentze; Alexander Scharf; Jan Degenhardt; Kai-Sven Heling; Peter Kozlowski; Kathrin Trautmann; Kai Jahns; Anne Geipel; Ismail Tekesin; Michael Elsässer; Lucas Wilhelm; Ingo Gottschalk; Jan-Erik Baumüller; Cahit Birdir; Felix Zöllner; Aline Wolter; Johanna Schenk; Tascha Gehrke; Corinna Keil; Jimmy Espinosa; Roland Axt-Fliedner Journal: J Clin Med Date: 2022-08-05 Impact factor: 4.964